Why the study?
Do vasodilating beta-blockers preserve insulin sensitivity compared to conventional beta-blockers in hypertensive patients with insulin resistance?
Do vasodilating beta-blockers preserve insulin sensitivity compared to conventional beta-blockers in hypertensive patients with insulin resistance?
Vasodilating beta-blockers may be advantageous for hypertensive patients with insulin resistance or type 2 diabetes as they do not impair insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
May support vasodilating beta-blockers in insulin-resistant hypertension; leaves open randomized confirmation.
Stephan Jacob (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: